Keyphrases
Fibroblast Growth Factor 23 (FGF23)
100%
Chronic Kidney Disease
100%
Adverse Clinical Outcomes
100%
Cardiovascular Disease
42%
Left Ventricular Hypertrophy
28%
End-stage Renal Disease
28%
Epidemiology
14%
Pathophysiology
14%
Phosphate
14%
Cardiovascular Mortality
14%
Novel Risk Factors
14%
Leading Causes of Death
14%
Clinical Outcomes
14%
Vitamin D
14%
End Organ
14%
Organ Toxicity
14%
Medicine and Dentistry
Chronic Kidney Disease
100%
Fibroblast Growth Factor 23
100%
Cardiovascular Disease
42%
Left Ventricular Hypertrophy
28%
End Stage Renal Disease
28%
Pathophysiology
14%
Cohort Effect
14%
Cardiovascular Mortality
14%
Organ Toxicity
14%
Vitamin D
14%
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Kidney Failure
100%
Fibroblast Growth Factor 23
100%
Cardiovascular Disease
42%
Heart Left Ventricle Hypertrophy
28%
End Stage Renal Disease
28%
Organ Toxicity
14%
Cardiovascular Mortality
14%
Vitamin D
14%
Pathophysiology
14%